glp 1 and substance use disorder GLP-1 receptor agonists show promise in treating disorders The GLP-1 revolution: What UAB

Quick Takeaways Human sleep trials used 25 nmol/kg IV for 7 consecutive nights The commonly used 100250 mcg subcutaneous protocol lacks direct clinical validation DSIP demonstrates an unusually wide safety margin in animal and human research Most evidence comes from small 1980s pilot studies, not modern RCTs What DSIP Actually Is (And Why Its Misunderstood) DSIP is a nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of sleeping rabbits

Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study

The brain receives satiety signals from two completely independent pathways

Zimecki, M., Actor, J

Astrup A, Rossner S, Van Gaal L, et al